Cerenome (CNSY) FCF Margin Growth (3y) (2014 - 2026)
Powered by 
Analysis
Cerenome (CNSY) FCF Margin Growth (3y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | -1,272.00 |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | -2,228.00 |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | -5,426.00 |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 9,545.00 |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | 4,612.00 |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | -3,088.00 |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 14,060.00 |
| 10 | Cerenome | 20.42 Mn | 11.83 Mn | - | -170,990.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -170,990.00 |
| Mar 31, 2026 | 47,765.00 |
| Dec 31, 2025 | 301,177.00 |
| Sep 30, 2025 | 424,307.00 |
| Mar 31, 2019 | -7,073.00 |
| Dec 31, 2018 | 20,354.00 |
| Sep 30, 2018 | 32,522.00 |
| Jun 30, 2018 | -10,206.00 |
| Mar 31, 2018 | 766.00 |
| Dec 31, 2017 | -41,173.00 |
| Sep 30, 2017 | 55,513.00 |
| Jun 30, 2017 | 54,060.00 |
| Mar 31, 2017 | 1,980.00 |
| Dec 31, 2016 | 3,434.00 |
| Sep 30, 2016 | -14,003.00 |
| Jun 30, 2016 | 2,605.00 |
| Mar 31, 2016 | 34,237.00 |
| Dec 31, 2015 | -16,603.00 |
| Sep 30, 2015 | -2,236.00 |
| Jun 30, 2015 | 11,409.00 |